dasatinib (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
97
Structured Review
MedChemExpress
dasatinib
Dasatinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 200 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dasatinib/Dasatinib/pm42469883-92-25-28
Average 97 stars, based on 200 article reviews
Dasatinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 200 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dasatinib/Dasatinib/pm42469883-92-25-28
Average 97 stars, based on 200 article reviews
dasatinib - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
Saline:Article Title: Ursolic acid inhibits the proliferation and migration of breast cancer cells by suppressing the hippo/YAP signaling pathway. Article Snippet: BACKGROUND: Breast cancer (BC) is one of the most frequent malignant tumors, with high morbidity and fatality rates.. Abnormalities in the Hippo pathway or YAP overexpression alter the cell proliferation–apoptosis equilibrium, which promotes cancer progression.. Ursolic acid (UA), a naturally occurring triterpenoid carboxylic acid, exhibits preventive and anticancer properties. Cell Culture:Article Title: Suppression of the myofibroblastic cancer-associated fibroblast phenotype to enhance anti-PD-1 response. Article Snippet: .. ACCEPTED MANUSCRIPT AR TIC LE IN R ES S ARTICLE IN PRESS Cell culture drug treatments Nilotinib (HY-10159), Injection:Article Title: Dasatinib ameliorates immune checkpoint inhibitor-associated myocarditis in mice Article Snippet: To establish the ICIM model, mice received intraperitoneal injections of anti-mouse PD-L1 (BE0101, BioXcell; 200 μg per mouse) and anti-mouse CTLA−4 (BE0164, BioXcell; 200 μg per mouse) twice weekly for a total of six injections, as previously described.1,12,25,26 The mice were randomly divided into three groups (n = 10 per group): (1) the control group (Con group), which received the IgG2a isotype control (BE0085; BioXcell; 200 μg per mouse); (2) the ICIM model group; and (3) the ICIM + dasatinib group (Treat group). .. Starting two days after the final ICI injection, the mice in the treatment group received 50 mg/kg of |